Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Strahlentherapie und Onkologie
Published in: Strahlentherapie und Onkologie 5/2017

01-05-2017 | Literatur kommentiert

Die Rolle der Beckenbestrahlung beim nodal-negativen Adenokarzinom der Prostata bleibt unklar

Langzeitergebnisse der GETUG-01-Studie

Authors: Dr. med. Matthias G. Hautmann, Prof. Dr. med. Oliver Kölbl

Published in: Strahlentherapie und Onkologie | Issue 5/2017

Login to get access

Auszug

Bei der hier zu kommentierenden Studie handelt es sich um die Langzeitergebnisse der GETUG-01-Studie (French Genitourinary Study Group). Ziel der Arbeit war es, das krankheitsfreie Überleben und das Gesamtüberleben des Studienkollektivs auszuwerten und eine potenzielle Interaktion zwischen antihormoneller Therapie und Bestrahlung der pelvinen Lymphknotenstationen beim Prostatakarzinom zu erfassen. …
Literature
1.
Asbell SO, Martz KL, Shin KH et al (1998) Impact of surgical staging in evaluating the radiotherapeutic outcome in RTOG #77-06, a phase III study for T1BN0M0 (A2) and T2N0M0 (B) prostate carcinoma. Int J Radiat Oncol Biol Phys 40(4):769–782CrossRefPubMed
2.
Lawton CA, DeSilvio M, Roach M et al (2007) An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions. Int J Radiat Oncol Biol Phys 69(3):646–655CrossRefPubMedPubMedCentral
3.
Pommier P, Chabaud S, Lagrange JL et al (2007) Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01. J Clin Oncol 25(34):5366–5373CrossRefPubMed
4.
D’Amico AV, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280(11):969–974CrossRefPubMed
Metadata
Title
Die Rolle der Beckenbestrahlung beim nodal-negativen Adenokarzinom der Prostata bleibt unklar
Langzeitergebnisse der GETUG-01-Studie
Authors
Dr. med. Matthias G. Hautmann
Prof. Dr. med. Oliver Kölbl
Publication date
01-05-2017
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 5/2017
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-017-1125-x

Other articles of this Issue 5/2017

Strahlentherapie und Onkologie 5/2017 Go to the issue

Original Article

Radical hypo-fractionated radiotherapy with volumetric modulated arc therapy in lung cancer

Original Article

Better compliance with hypofractionation vs. conventional fractionation in adjuvant breast cancer radiotherapy

Original Article

Framework for radiation pneumonitis risk stratification based on anatomic and perfused lung dosimetry

Original Article

Complementary and alternative medicine in radiation oncology

Original Article

Clinical relevance of the M1b and M1c descriptors from the proposed TNM 8 classification of lung cancer

Original Article

Fully automated VMAT treatment planning for advanced-stage NSCLC patients